Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application PCT/US2010/042302, filed Jul 16, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,859,467 | Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 10,047,357 | Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 10,920,216 | Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts In force · High confidence | BioAtla, Inc. | In force | High confidence | ||
| US 10,106,788 | Simultaneous, Integrated Selection and Evolution of Antibody/Protein Performance and Expression in Production Hosts Lapsed Oct 23, 2026 on the fee record Ended Oct 23, 2026 · Low confidence | BioAtla, Inc. | Lapsed Oct 23, 2026 on the fee record | Ended Oct 23, 2026 | Low confidence |
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by BioAtla Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.